Suppr超能文献

戈勒斯坦省2型糖尿病患者中基于芳基酯酶的活性与对氧磷酶1基因变异之间的关系评估。

Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province.

作者信息

Khajeniazi Safoura, Shakeri Raheleh, Marjani Abdoljalal

机构信息

1Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

2Department of Biochemistry and Biophysics, Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Indian J Clin Biochem. 2020 Apr;35(2):239-244. doi: 10.1007/s12291-019-00822-3. Epub 2019 Mar 5.

Abstract

Arylesterase activity of Paraoxonase-1 (PON1) enzyme may be play important role in initiation and progression of several diseases. Activity or serum level of Arylesterase can be affected by many genetic alterations such as SNPs. The reduction in the activity and serum level of Arylesterase could be involved in Type2 diabetes mellitus (T2DM). The aim of this investigation is to examine the association between Arylesterase activity and promoter polymorphism (- 108C > T) of PON1gene in patients with T2DM in Golestan Province, northern area of Iran. Achievement of this purpose was due to DNA obtaining from blood then SNP determination using PCR-RFLP and Arylesterase activity measurement in the serum of 90 normal individuals and 90patients suffering diabetes. Data was processed by SPSS software version 16. The significant association was observed between the Arylesterase activity and three genotypes of PON1 gene such as CC, CT, and TT in subjects with T2DM. In the present study, it has been shown level of Arylestrase activity of PON1 in patients (117.33 ± 63.96) is lower than it in control group (289.33 ± 68.38);  < 0.05. Our results declared that activity of Arylesterase in diabetic patients was significantly lower than the healthy individuals.

摘要

对氧磷酶-1(PON1)的芳基酯酶活性可能在多种疾病的发生和发展中起重要作用。芳基酯酶的活性或血清水平会受到许多基因改变(如单核苷酸多态性)的影响。芳基酯酶活性和血清水平的降低可能与2型糖尿病(T2DM)有关。本研究的目的是检测伊朗北部戈勒斯坦省T2DM患者中芳基酯酶活性与PON1基因启动子多态性(-108C>T)之间的关联。通过采集血液获取DNA,然后使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术测定单核苷酸多态性,并对90名正常个体和90名糖尿病患者的血清进行芳基酯酶活性测定,从而实现这一目的。数据用SPSS 16.0软件进行处理。在T2DM患者中,观察到芳基酯酶活性与PON1基因的三种基因型(如CC、CT和TT)之间存在显著关联。在本研究中,已表明患者PON1的芳基酯酶活性水平(117.33±63.96)低于对照组(289.33±68.38);P<0.05。我们的结果表明,糖尿病患者的芳基酯酶活性显著低于健康个体。

相似文献

8
Alzheimer's Disease and Paraoxonase 1 () Gene Polymorphisms.阿尔茨海默病与对氧磷酶1()基因多态性
Open Biochem J. 2017 Jun 13;11:47-55. doi: 10.2174/1874091X01711010047. eCollection 2017.
10
gene polymorphisms in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的基因多态性。
J Clin Pathol. 2018 Nov;71(11):963-970. doi: 10.1136/jclinpath-2018-205194. Epub 2018 Jun 1.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验